Bill Meury

Bill Meury serves as CEO at Anthos Therapeutics. Anthos Therapeutics operates in the research sector with approximately 54.0 employees. The company is headquartered in Boston, Massachusetts.

Industry & Role Insights

• • MessageCEO tracks 2,961 executives in the research sector.
• • We have verified contacts for 2 executives at Anthos Therapeutics.
• • 3,781 executive contacts are available in Massachusetts.
• • Our database includes 201,464 c suite-level executives.

Outlook Zendesk Microsoft Office 365 Amazon AWS Salesforce WordPress.org Google Tag Manager Mobile Friendly Google Font API Vimeo Remote AI

biotechnology research anticoagulant factor xi abelacimab atrial fibrillation cancer associated thrombosis venous thromboembolism stroke prevention blood clot treatment hemostasis-sparing clinical trials fda fast track designation cardiovascular care biopharmaceutical clinical development cardiovascular diseases thrombosis prevention safety profile innovative therapy patient-centric drug interactions subcutaneous administration intravenous infusion monoclonal antibody thromboembolic disease chronic treatment acute indications oral anticoagulants pharmacokinetics pharmacodynamics surgical patients clinical efficacy long-acting anticoagulant patient advocacy clinical outcomes drug safety dosing regimen monthly injection adverse effects drug development research & development cardiac events investigational new drug biotech innovation cancer treatment healthcare professionals patient quality of life biotech investment clinical data new therapeutic options unmet medical needs health care health wellness & fitness hospital & health care

NM

Nikhil Mehta Chief Technical and Regulatory Officer at Anthos Therapeutics

SN

Srikanth Nandiraju Chief Technology Officer at 1Cell.Ai Inc.

SD

Surinnder Dang Chief Business Officer at 1Cell.Ai Inc.

M

Mark Chief Executive Officer at 23Strands

IT

Ilia Tikhomirov Chief Executive Officer at 35Pharma

Outreach Guidance — research Sector

Executives like Bill Meury in the research sector receive targeted outreach from sales teams, recruiters, and investors. To stand out, personalize your message with industry-specific context and a clear, specific value proposition relevant to their role at Anthos Therapeutics.

Bill Meury's Position in the MessageCEO Database

• •Bill Meury is 1 of 2 verified executive contacts we track at Anthos Therapeutics.
• •2,871 verified executive contacts in research are in the MessageCEO database.
• •3,577 verified executive contacts in Massachusetts are in the database.
• •25 verified contacts work at research companies in the 54.0 employee range (same size as Anthos Therapeutics).

Executive contact data compiled from public business filings, LinkedIn public profiles, company press materials, and verified outbound email testing. We do not publish personal addresses or sensitive identifiers. Methodology & sources · Removal requests handled at /remove-info · Updated November 2026.

How do I reach Bill Meury directly?

Bill Meury's verified email address is available to MessageCEO Pro subscribers. They currently serve as CEO at Anthos Therapeutics. Access direct contact info to skip gatekeepers and reach the decision maker.

What company does Bill Meury work for?

Bill Meury is CEO at Anthos Therapeutics, a company in the research sector with 54.0 employees. The company is based in Boston, Massachusetts.

Can I pitch or sell to Bill Meury?

As CEO at Anthos Therapeutics, Bill Meury is a key decision-maker in the research sector. MessageCEO Pro gives you verified email to reach Bill Meury directly — ideal for B2B sales, partnerships, and executive recruiting.

What industry is Bill Meury in?

Bill Meury works in the research industry as CEO at Anthos Therapeutics. MessageCEO provides verified contact information for executives across all major industries.

Is Bill Meury's contact information verified?

Yes. MessageCEO verifies executive contact information through multiple data sources and regular validation checks. Bill Meury's profile is kept up-to-date with the latest available information.

Last updated: November 4, 2026